Abstract
A literature review of the most current publications studying lower urinary tract symptoms (LUTS) and findings in diabetic women was conducted including articles from January 2013 to April 2014. Current reports consistently note that aging and obesity are significantly associated with worsened LUTS in diabetic women. Glucosuria has variable effects on urodynamic parameters and LUTS, but has a significant association with urinary tract infection (UTI) and incontinence at clinically relevant numbers, such as HbA1C values. The presence of severe nocturia in diabetic patients warrants careful surveillance for cardiovascular risks given the significant association with mortality. Diabetics appear to be at higher risk for colonization with the virulent, extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella species in UTI. Novel therapies in glycemic control and for diabetic bladder dysfunction are undergoing animal model trials with encouraging results. The most promising of these includes stem cell therapy, although a need exists for human studies.
Similar content being viewed by others
References
Papers of particular interest, published recently, have been highlighted as: • Of importance •• Of major importance
Samsioe G, Heraib F, Lidfeldt J, et al. Urogenital symptoms in women aged 50-59 years. Women's Health in Lund Area (WHILSA) Study Group. Gynecol Endocrinol Off J Int Soc Gynecol Endocrinol. 1999;13(2):113–7.
Brown JS, Seeley DG, Fong J, Black DM, Ensrud KE, Grady D. Urinary incontinence in older women: who is at risk? Study of Osteoporotic Fractures Research Group. Obstet Gynecol. 1996;87(5 Pt 1):715–21.
Farrell SA, Allen VM, Baskett TF. Parturition and urinary incontinence in primiparas. Obstet Gynecol. 2001;97(3):350–6.
Brown JS, Vittinghoff E, Lin F, Nyberg LM, Kusek JW, Kanaya AM. Prevalence and risk factors for urinary incontinence in women with type 2 diabetes and impaired fasting glucose: findings from the National Health and Nutrition Examination Survey (NHANES) 2001-2002. Diabetes Care. 2006;29(6):1307–12.
Brown JS, Wing R, Barrett-Connor E, et al. Lifestyle intervention is associated with lower prevalence of urinary incontinence: the Diabetes Prevention Program. Diabetes Care. 2006;29(2):385–90.
Foldspang A, Hvidman L, Mommsen S, Nielsen JB. Risk of postpartum urinary incontinence associated with pregnancy and mode of delivery. Acta Obstet Gynecol Scand. 2004;83(10):923–7.
Ebbesen MH, Hannestad YS, Midthjell K, Hunskaar S. Diabetes and urinary incontinence - prevalence data from Norway. Acta Obstet Gynecol Scand. 2007;86(10):1256–62.
Danforth KN, Townsend MK, Lifford K, Curhan GC, Resnick NM, Grodstein F. Risk factors for urinary incontinence among middle-aged women. Am J Obstet Gynecol. 2006;194(2):339–45.
Benfield T, Jensen JS, Nordestgaard BG. Influence of diabetes and hyperglycaemia on infectious disease hospitalisation and outcome. Diabetologia. 2007;50(3):549–54.
Simkhada R. Urinary tract infection and antibiotic sensitivity pattern among diabetics. Nepal Med Coll J NMCJ. 2013;15(1):1–4.
Patterson JE, Andriole VT. Bacterial urinary tract infections in diabetes. Infect Dis Clin N Am. 1997;11(3):735–50.
Kesah CN, Coker AO, Alabi SA, Olukoya DK. Prevalence, antimicrobial properties and beta-lactamase production of haemolytic enterobacteria in patients with diarrhoea and urinary tract infections in Legos, Nigeria. Cent Afr J Med. 1996;42(5):147–50.
Muller LM, Gorter KJ, Hak E, et al. Increased risk of common infections in patients with type 1 and type 2 diabetes mellitus. Clin Infect Dis Off Publ Infect Dis Soc Am. 2005;41(3):281–8.
Bani-Issa W, Almomani F, Eldeirawi K. Urinary incontinence among adult women with diabetes in Jordan: epidemiology, correlates and perceived impact on emotional and social well-being. J Clin Nurs. 2013.
Palleschi G, Pastore AL, Maggioni C, et al. Overactive bladder in diabetes mellitus patients: a questionnaire-based observational investigation. World J Urol. 2013.
Ahmed HM, Osman VA, Al-Alaf SK, Al-Tawil NG. Prevalence of urinary incontinence and probable risk factors in a sample of kurdish women. Sultan Qaboos Univ Med J. 2013;13(2):269–74.
Appa AA, Brown JS, Creasman J, et al. Clinical predictors and significance of postvoid residual volume in women with diabetes. Diabetes Res Clin Pract. 2013;101(2):164–9.
Chung MS, Chuang YC, Lee JJ, Lee WC, Chancellor MB, Liu RT. Prevalence and associated risk factors of nocturia and subsequent mortality in 1,301 patients with type 2 diabetes. Int Urol Nephrol. 2014. The alarming significance between nocturia of ≥ 3 times per night and cardiovascular mortality in diabetic patients warrants a provider to urge the patient to maintain vigilant surveillance with her primary care provider in routine cardiovascular risk screenings. In a sense, the symptom of nocturia may prove to be a valuable warning in the care of diabetic patients.
Deli G, Bosnyak E, Pusch G, Komoly S, Feher G. Diabetic neuropathies: diagnosis and management. Neuroendocrinology. 2013;98(4):267–80.
Lee WC, Wu HC, Huang KH, Wu HP, Yu HJ, Wu CC. Hyposensitivity of C-fiber afferents at the distal extremities as an indicator of early stages diabetic bladder dysfunction in type 2 diabetic women. PLoS One. 2014;9(1):e86463.
Kirschner-Hermanns R, Daneshgari F, Vahabi B, Birder L, Oelke M, Chacko S. Does diabetes mellitus-induced bladder remodeling affect lower urinary tract function? ICI-RS 2011. Neurourol Urodyn. 2012;31(3):359–64.
Kim JH, Lee SR, Song YS, Lee HJ. Stem cell therapy in bladder dysfunction: where are we? And where do we have to go? BioMed Res Int. 2013;2013:930713. Stem cell therapy appears to have the most promising projection for future LUTS therapies, but focused efforts must be made to conduct human studies.
Daneshgari F, Liu G, Imrey PB. Time dependent changes in diabetic cystopathy in rats include compensated and decompensated bladder function. J Urol. 2006;176(1):380–6.
Daneshgari F, Huang X, Liu G, Bena J, Saffore L, Powell CT. Temporal differences in bladder dysfunction caused by diabetes, diuresis, and treated diabetes in mice. Am J Physiol Regul Integr Comp Physiol. 2006;290(6):R1728–35.
Hammar N, Farahmand B, Gran M, Joelson S, Andersson SW. Incidence of urinary tract infection in patients with type 2 diabetes. Experience from adverse event reporting in clinical trials. Pharmacoepidemiol Drug Saf. 2010;19(12):1287–92.
Kullmann FA, Wells GI, McKenna D, Thor KB. Excitatory effects of bombesin receptors in urinary tract of normal and diabetic rats in vivo. Life Sci. 2014;100(1):35–44.
Ren LM, Zhuo YJ, Hao ZS, He HM, Lu HG, Zhao D. Berberine improves neurogenic contractile response of bladder detrusor muscle in streptozotocin-induced diabetic rats. J Ethnopharmacol. 2013;150(3):1128–36.
Changxiao H, Zhengyong Y, Shibing Y, et al. Clinical and urodynamic evaluation of women referred with diabetes mellitus. Int Urogynecol J. 2014.
Ding L, Song T, Yi C, et al. Transcutaneous electrical nerve stimulation (TENS) improves the diabetic cytopathy (DCP) via up-regulation of CGRP and cAMP. PLoS One. 2013;8(2):e57477.
Kaplan SA, Te AE, Blaivas JG. Urodynamic findings in patients with diabetic cystopathy. J Urol. 1995;153(2):342–4.
Starer P, Libow L. Cystometric evaluation of bladder dysfunction in elderly diabetic patients. Arch Intern Med. 1990;150(4):810–3.
Chang TC, Chang SR, Hsiao SM, Hsiao CF, Chen CH, Lin HH. Factors associated with fecal incontinence in women with lower urinary tract symptoms. J Obstet Gynaecol Res. 2013;39(1):250–5.
Stav K, Shilo Y, Zisman A, Lindner A, Leibovici D. Comparison of lower urinary tract symptoms between women with detrusor overactivity and impaired contractility, and detrusor overactivity and preserved contractility. J Urol. 2013;189(6):2175–8.
Aswani SM, Chandrashekar U, Shivashankara K, Pruthvi B. Clinical profile of urinary tract infections in diabetics and non-diabetics. Australas Med J. 2014;7(1):29–34. The above study discusses how diabetics appear to be at higher risk for the most virulent strains of the common UTI microbes (extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella species; ESBL-EK), so continued research in therapies against these strains is warranted. E. coli has shown maximum sensitivity to carbapenems and the least susceptibility to ampicillin.
Mody L, Juthani-Mehta M. Urinary tract infections in older women: a clinical review. JAMA J Am Med Assoc. 2014;311(8):844–54.
Tsai SW, Kung FT, Chuang FC, Ou YC, Wu CJ, Huang KH. Evaluation of the relationship between urodynamic examination and urinary tract infection based on urinalysis results. Taiwan J Obstet Gynecol. 2013;52(4):493–7.
Mamun Mahmud H, Qureshi S, Kumar D, Farman S. Pyuric diabetic patients: a tertiary centre experience from Karachi. Pak J Med Sci. 2014;30(1):77–80.
Macvane SH, Tuttle LO, Nicolau DP. Impact of extended-spectrum beta-lactamase-producing organisms on clinical and economic outcomes in patients with urinary tract infection. J Hosp Med Off Publ Soc Hosp Med. 2014;9(4):232–8. The above study discusses how diabetics appear to be at higher risk for the most virulent strains of the common UTI microbes (extended-spectrum, β-lactamase-producing Escherichia coli and Klebsiella species; ESBL-EK), so continued research in therapies against these strains is warranted. E. coli has shown maximum sensitivity to carbapenems and the least susceptibility to ampicillin.
Johnsson KM, Ptaszynska A, Schmitz B, Sugg J, Parikh SJ, List JF. Urinary tract infections in patients with diabetes treated with dapagliflozin. J Diabetes Complicat. 2013;27(5):473–8.
Dixon L, Winkler M. Emphysematous cystitis: a tympanic bladder. BMJ Case Rep. 2013;2013.
Hanna-Mitchell AT, Ruiz GW, Daneshgari F, Liu G, Apodaca G, Birder LA. Impact of diabetes mellitus on bladder uroepithelial cells. Am J Physiol Regul Integr Comp Physiol. 2013;304(2):R84–93.
Wai CY, Curto TM, Zyczynski HM, et al. Patient satisfaction after midurethral sling surgery for stress urinary incontinence. Obstet Gynecol. 2013;121(5):1009–16.
Nicolle LE, Capuano G, Ways K, Usiskin K. Effect of canagliflozin, a sodium glucose co-transporter 2 (SGLT2) inhibitor, on bacteriuria and urinary tract infection in subjects with type 2 diabetes enrolled in a 12-week, phase 2 study. Curr Med Res Opin. 2012;28(7):1167–71.
Uzun H, Ogullar S, Sahin SB, et al. Increased bladder wall thickness in diabetic and nondiabetic women with overactive bladder. Int Neurourol J. 2013;17(2):67–72.
Compliance with Ethics Guidelines
Conflict of Interest
Dr. Rebecca James and Dr. Adonis Hijaz each declare no potential conflicts of interest.
Human and Animal Rights and Informed Consent
This article does not contain any studies with human or animal subjects performed by any of the authors.
Author information
Authors and Affiliations
Corresponding author
Additional information
This article is part of the Topical Collection on Lower Urinary Tract Symptoms & Voiding Dysfunction
Rights and permissions
About this article
Cite this article
James, R., Hijaz, A. Lower Urinary Tract Symptoms in Women with Diabetes Mellitus: A Current Review. Curr Urol Rep 15, 440 (2014). https://doi.org/10.1007/s11934-014-0440-3
Published:
DOI: https://doi.org/10.1007/s11934-014-0440-3